Process View
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fibroblast growth factor stimulus.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to fibroblast growth factor"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FGFR2 | fibroblast growth factor receptor 2 | 1.000 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.992 | ||
| IL8 | interleukin 8 | 0.979 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.928 | Human | |
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.898 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.891 | Human | |
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.816 | Human | |
| CCL2 | chemokine (C-C motif) ligand 2 | 0.815 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.797 | Human | |
| EGR3 | early growth response 3 | 0.797 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.788 | ||
| STAMBP | STAM binding protein | 0.748 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.707 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.707 | Human | |
| FGF10 | fibroblast growth factor 10 | 0.701 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.698 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.677 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.668 | Human | |
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.661 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.645 | ||
| PLAU | plasminogen activator, urokinase | 0.645 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.631 | ||
| NRP1 | neuropilin 1 | 0.628 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.605 | Human | |
| CCL8 | chemokine (C-C motif) ligand 8 | 0.581 | Human | |
| EGR2 | early growth response 2 | 0.565 | Human | |
| IL1B | interleukin 1, beta | 0.556 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.542 | Human | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.474 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.434 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.425 | ||
| SPRY2 | sprouty homolog 2 (Drosophila) | 0.407 | Mouse Fly | |
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.402 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.358 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.345 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.342 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.332 | Human | |
| HDAC7 | histone deacetylase 7 | 0.319 | ||
| NOTCH1 | notch 1 | 0.314 | ||
| ZUFSP | zinc finger with UFM1-specific peptidase domain | 0.313 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.289 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.289 | Human | |
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.288 | ||
| ABI1 | abl-interactor 1 | 0.269 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.265 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.250 | ||
| ITSN1 | intersectin 1 (SH3 domain protein) | 0.245 | ||
| SH2D1A | SH2 domain containing 1A | 0.242 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.220 | ||
| NOTCH3 | notch 3 | 0.219 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.212 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.212 | Human | |
| TESK1 | testis-specific kinase 1 | 0.210 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.207 | ||
| JAG1 | jagged 1 | 0.202 | Human | |
| FN1 | fibronectin 1 | 0.193 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.186 | ||
| EGR1 | early growth response 1 | 0.180 | Human | |
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.166 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.162 | Human | |
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.161 | ||
| TSG101 | tumor susceptibility gene 101 | 0.158 | ||
| IER3 | immediate early response 3 | 0.150 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.149 | Human | |
| MSN | moesin | 0.147 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.146 | Human | |
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.146 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.146 | ||
| IDE | insulin-degrading enzyme | 0.142 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.138 | ||
| LIN28B | lin-28 homolog B (C. elegans) | 0.137 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.132 | ||
| FGF7 | fibroblast growth factor 7 | 0.127 | ||
| NOTCH2 | notch 2 | 0.127 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.121 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.118 | ||
| VEGFA | vascular endothelial growth factor A | 0.118 | Rat | |
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.117 | Mouse | |
| COL2A1 | collagen, type II, alpha 1 | 0.116 | Rat | |
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.110 | ||
| STMN2 | stathmin-like 2 | 0.106 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.106 | Human | |
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.106 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.103 | Human | |
| CD83 | CD83 molecule | 0.100 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.092 | Human | |
| CCL22 | chemokine (C-C motif) ligand 22 | 0.091 | Human | |
| CCL7 | chemokine (C-C motif) ligand 7 | 0.089 | Human | |
| FBLN1 | fibulin 1 | 0.089 | ||
| IL4R | interleukin 4 receptor | 0.088 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.087 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.087 | ||
| INHBA | inhibin, beta A | 0.087 | ||
| BMP2 | bone morphogenetic protein 2 | 0.081 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.079 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.078 | ||
| UBD | ubiquitin D | 0.077 | ||
| TNC | tenascin C | 0.076 | ||
| CH25H | cholesterol 25-hydroxylase | 0.075 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.075 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.074 | Human | |
| THBS1 | thrombospondin 1 | 0.072 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.071 | ||
| KRT8 | keratin 8 | 0.070 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.070 | ||
| PGF | placental growth factor | 0.069 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.067 | Mouse | |
| RET | ret proto-oncogene | 0.064 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.064 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.063 | ||
| PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.062 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.060 | ||
| SELE | selectin E | 0.060 | ||
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.060 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.060 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.059 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.059 | ||
| IFNG | interferon, gamma | 0.057 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.056 | ||
| MXRA5 | matrix-remodelling associated 5 | 0.055 | ||
| KLB | klotho beta | 0.055 | ||
| PLAT | plasminogen activator, tissue | 0.054 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.053 | ||
| STX5 | syntaxin 5 | 0.053 | ||
| JAK1 | Janus kinase 1 | 0.052 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.052 | Mouse | |
| GDF9 | growth differentiation factor 9 | 0.051 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.051 | ||
| ERBB2IP | erbb2 interacting protein | 0.051 | ||
| HAS2 | hyaluronan synthase 2 | 0.050 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.050 | ||
| FLNA | filamin A, alpha | 0.049 | ||
| MDFI | MyoD family inhibitor | 0.046 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.045 | ||
| MTF2 | metal response element binding transcription factor 2 | 0.044 | ||
| SLAMF8 | SLAM family member 8 | 0.043 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.043 | ||
| TCF4 | transcription factor 4 | 0.043 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.043 | ||
| BMP7 | bone morphogenetic protein 7 | 0.042 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.041 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.041 | ||
| BCL2A1 | BCL2-related protein A1 | 0.041 | ||
| TCEAL5 | transcription elongation factor A (SII)-like 5 | 0.041 | ||
| APC | adenomatous polyposis coli | 0.041 | ||
| PAX8 | paired box 8 | 0.040 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.039 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.039 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.039 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.038 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.038 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.037 | ||
| DUSP2 | dual specificity phosphatase 2 | 0.037 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.037 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.036 | ||
| OSMR | oncostatin M receptor | 0.035 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.035 | Fly | |
| PSEN1 | presenilin 1 | 0.035 | ||
| EEA1 | early endosome antigen 1 | 0.035 | ||
| HIC1 | hypermethylated in cancer 1 | 0.035 | ||
| GGA3 | golgi-associated, gamma adaptin ear containing, ARF binding protein 3 | 0.035 | ||
| AP1G1 | adaptor-related protein complex 1, gamma 1 subunit | 0.035 | ||
| OCRL | oculocerebrorenal syndrome of Lowe | 0.034 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.034 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.032 | ||
| TNF | tumor necrosis factor | 0.032 | ||
| CTGF | connective tissue growth factor | 0.031 | Mouse | |
| ERRFI1 | ERBB receptor feedback inhibitor 1 | 0.031 | ||
| COL11A1 | collagen, type XI, alpha 1 | 0.031 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.031 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.030 | ||
| ACTN4 | actinin, alpha 4 | 0.030 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.028 | ||
| NOSTRIN | nitric oxide synthase trafficker | 0.028 | ||
| PF4 | platelet factor 4 | 0.028 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.028 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.028 | Zebrafish | |
| FPR3 | formyl peptide receptor 3 | 0.028 | ||
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.028 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.027 | ||
| SPRY1 | sprouty homolog 1, antagonist of FGF signaling (Drosophila) | 0.027 | Mouse Fly | |
| FZD1 | frizzled homolog 1 (Drosophila) | 0.027 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.027 | Mouse | |
| PLEK | pleckstrin | 0.027 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.027 | ||
| JUNB | jun B proto-oncogene | 0.026 | ||
| IPO13 | importin 13 | 0.026 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.026 | ||
| SRGN | serglycin | 0.026 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.026 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.025 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.025 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.025 | ||
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.025 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.024 | ||
| FGFR4 | fibroblast growth factor receptor 4 | 0.024 | ||
| EFNA1 | ephrin-A1 | 0.024 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.024 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.024 | ||
| MT2A | metallothionein 2A | 0.024 | ||
| GORASP1 | golgi reassembly stacking protein 1, 65kDa | 0.023 | ||
| STC1 | stanniocalcin 1 | 0.023 | ||
| ZNF331 | zinc finger protein 331 | 0.023 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.023 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.023 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.023 | ||
| FBN1 | fibrillin 1 | 0.023 | ||
| EGFL6 | EGF-like-domain, multiple 6 | 0.023 | ||
| NCK1 | NCK adaptor protein 1 | 0.023 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.023 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.023 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.022 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.022 | ||
| GPNMB | glycoprotein (transmembrane) nmb | 0.022 | ||
| COL7A1 | collagen, type VII, alpha 1 | 0.022 | ||
| C2 | complement component 2 | 0.021 | ||
| EGFR | epidermal growth factor receptor | 0.021 | ||
| JUP | junction plakoglobin | 0.021 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.021 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.021 | Rat | |
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.021 | ||
| EMP1 | epithelial membrane protein 1 | 0.021 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.021 | ||
| CD69 | CD69 molecule | 0.020 | ||
| CHMP1B | chromatin modifying protein 1B | 0.020 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.020 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.020 | ||
| BTG2 | BTG family, member 2 | 0.020 | ||
| CCL17 | chemokine (C-C motif) ligand 17 | 0.020 | Human | |
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.020 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.020 | ||
| CPD | carboxypeptidase D | 0.020 | ||
| MARCKS | myristoylated alanine-rich protein kinase C substrate | 0.020 | ||
| IL7R | interleukin 7 receptor | 0.020 | ||
| NTM | neurotrimin | 0.019 | ||
| SOX2 | SRY (sex determining region Y)-box 2 | 0.019 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.019 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.019 | ||
| SLC7A11 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | 0.019 | ||
| SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.019 | ||
| VWF | von Willebrand factor | 0.019 | ||
| C5AR1 | complement component 5a receptor 1 | 0.019 | ||
| RAB5A | RAB5A, member RAS oncogene family | 0.019 | ||
| ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | 0.019 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.019 | ||
| TNPO1 | transportin 1 | 0.019 | ||
| FNDC1 | fibronectin type III domain containing 1 | 0.019 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.019 | ||
| SNRNP70 | small nuclear ribonucleoprotein 70kDa (U1) | 0.019 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.019 | ||
| CD84 | CD84 molecule | 0.019 | ||
| ANXA5 | annexin A5 | 0.018 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.018 | ||
| MPZL1 | myelin protein zero-like 1 | 0.018 | ||
| SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | 0.018 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.018 | ||
| MOBKL2B | MOB1, Mps One Binder kinase activator-like 2B (yeast) | 0.018 | ||
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.018 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.018 | ||
| SDC2 | syndecan 2 | 0.018 | ||
| DUSP4 | dual specificity phosphatase 4 | 0.018 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.018 | ||
| CD80 | CD80 molecule | 0.017 | ||
| NUDT3 | nudix (nucleoside diphosphate linked moiety X)-type motif 3 | 0.017 | ||
| VCAN | versican | 0.017 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.017 | ||
| BLNK | B-cell linker | 0.017 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.017 | ||
| SH3PXD2A | SH3 and PX domains 2A | 0.017 | ||
| AHR | aryl hydrocarbon receptor | 0.017 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.017 | ||
| TGOLN2 | trans-golgi network protein 2 | 0.017 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.016 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.016 | ||
| NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 | 0.016 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.016 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.016 | ||
| SFRP2 | secreted frizzled-related protein 2 | 0.016 | Human | |
| CD244 | CD244 molecule, natural killer cell receptor 2B4 | 0.016 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.016 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.016 | ||
| SGK1 | serum/glucocorticoid regulated kinase 1 | 0.016 | ||
| KYNU | kynureninase | 0.016 | ||
| IL13RA1 | interleukin 13 receptor, alpha 1 | 0.016 | ||
| CD86 | CD86 molecule | 0.016 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.016 | ||
| NOS3 | nitric oxide synthase 3 (endothelial cell) | 0.016 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.016 | ||
| NRP2 | neuropilin 2 | 0.016 | ||
| SPP1 | secreted phosphoprotein 1 | 0.016 | ||
| NELL2 | NEL-like 2 (chicken) | 0.016 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.016 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.015 | ||
| BTRC | beta-transducin repeat containing | 0.015 | ||
| FGF19 | fibroblast growth factor 19 | 0.015 | ||
| DARC | Duffy blood group, chemokine receptor | 0.015 | ||
| RUNX1 | runt-related transcription factor 1 | 0.015 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.015 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.015 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.015 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.015 | ||
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.015 | ||
| COL18A1 | collagen, type XVIII, alpha 1 | 0.015 | ||
| GREM1 | gremlin 1 | 0.015 | ||
| CORO1C | coronin, actin binding protein, 1C | 0.015 | ||
| CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.015 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.015 | ||
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.015 | ||
| RARB | retinoic acid receptor, beta | 0.014 | ||
| VRK2 | vaccinia related kinase 2 | 0.014 | Worm | |
| KRT18 | keratin 18 | 0.014 | ||
| MMP19 | matrix metallopeptidase 19 | 0.014 | ||
| EDN1 | endothelin 1 | 0.014 | ||
| NGF | nerve growth factor (beta polypeptide) | 0.014 | ||
| IL2RB | interleukin 2 receptor, beta | 0.014 | ||
| UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.014 | ||
| IL10 | interleukin 10 | 0.014 | ||
| SLC9A6 | solute carrier family 9 (sodium/hydrogen exchanger), member 6 | 0.014 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.014 | ||
| SIRPA | signal-regulatory protein alpha | 0.014 | ||
| JPH3 | junctophilin 3 | 0.014 | ||
| ETV5 | ets variant 5 | 0.014 | ||
| WNT4 | wingless-type MMTV integration site family, member 4 | 0.014 | ||
| SMC6 | structural maintenance of chromosomes 6 | 0.014 | ||
| TAOK1 | TAO kinase 1 | 0.014 | ||
| BGN | biglycan | 0.014 | ||
| HYAL1 | hyaluronoglucosaminidase 1 | 0.013 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.013 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.013 | ||
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.013 | ||
| VAV2 | vav 2 guanine nucleotide exchange factor | 0.013 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.013 | ||
| CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 | 0.013 | ||
| CAPZA2 | capping protein (actin filament) muscle Z-line, alpha 2 | 0.013 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.013 | ||
| IL1A | interleukin 1, alpha | 0.013 | ||
| TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 0.013 | ||
| DPYSL2 | dihydropyrimidinase-like 2 | 0.013 | ||
| IL4 | interleukin 4 | 0.013 | ||
| NAB2 | NGFI-A binding protein 2 (EGR1 binding protein 2) | 0.013 | ||
| IFNB1 | interferon, beta 1, fibroblast | 0.013 | ||
| SCARB2 | scavenger receptor class B, member 2 | 0.013 | ||
| PTX3 | pentraxin 3, long | 0.013 | ||
| IL32 | interleukin 32 | 0.013 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.013 | ||
| CDX2 | caudal type homeobox 2 | 0.013 | ||
| IL13 | interleukin 13 | 0.013 | ||
| CDC73 | cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | 0.013 | ||
| UTF1 | undifferentiated embryonic cell transcription factor 1 | 0.013 | ||
| PICALM | phosphatidylinositol binding clathrin assembly protein | 0.013 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.012 | ||
| PDE4D | phosphodiesterase 4D, cAMP-specific | 0.012 | ||
| CSGALNACT2 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 | 0.012 | ||
| IRS2 | insulin receptor substrate 2 | 0.012 | ||
| PIK3AP1 | phosphoinositide-3-kinase adaptor protein 1 | 0.012 | ||
| SPOCK1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 | 0.012 | ||
| EZR | ezrin | 0.012 | ||
| XCL1 | chemokine (C motif) ligand 1 | 0.012 | Human | |
| PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0.012 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.012 | ||
| ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | 0.012 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.012 | ||
| ANGPT2 | angiopoietin 2 | 0.012 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.012 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.012 | ||
| FGF4 | fibroblast growth factor 4 | 0.012 | ||
| PRRX1 | paired related homeobox 1 | 0.012 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.012 | Human | |
| IL11 | interleukin 11 | 0.012 | ||
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.012 | ||
| RABEP1 | rabaptin, RAB GTPase binding effector protein 1 | 0.012 | ||
| SIK1 | salt-inducible kinase 1 | 0.012 | ||
| USP49 | ubiquitin specific peptidase 49 | 0.012 | ||
| PKP4 | plakophilin 4 | 0.012 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.012 | ||
| PTPRE | protein tyrosine phosphatase, receptor type, E | 0.012 | ||
| GLMN | glomulin, FKBP associated protein | 0.012 | ||
| FSTL1 | follistatin-like 1 | 0.012 | ||
| WNT5A | wingless-type MMTV integration site family, member 5A | 0.012 | Mouse | |
| EPO | erythropoietin | 0.012 | ||
| PDE4B | phosphodiesterase 4B, cAMP-specific | 0.012 | ||
| EFNB2 | ephrin-B2 | 0.011 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.011 | ||
| IER2 | immediate early response 2 | 0.011 | ||
| LHX2 | LIM homeobox 2 | 0.011 | ||
| TLR2 | toll-like receptor 2 | 0.011 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.011 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.011 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.011 | ||
| FGF3 | fibroblast growth factor 3 | 0.011 | ||
| DLL4 | delta-like 4 (Drosophila) | 0.011 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.011 | ||
| CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.011 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.011 | ||
| CD33 | CD33 molecule | 0.011 | ||
| NPAS1 | neuronal PAS domain protein 1 | 0.011 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.011 | Mouse | |
| EPAS1 | endothelial PAS domain protein 1 | 0.011 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.011 | ||
| IGL@ | immunoglobulin lambda locus | 0.011 | ||
| CSNK1D | casein kinase 1, delta | 0.011 | ||
| CD63 | CD63 molecule | 0.011 | ||
| DBH | dopamine beta-hydroxylase (dopamine beta-monooxygenase) | 0.011 | ||
| ACVR1 | activin A receptor, type I | 0.011 | ||
| CALCR | calcitonin receptor | 0.011 | ||
| XCL2 | chemokine (C motif) ligand 2 | 0.011 | Human | |
| IL21R | interleukin 21 receptor | 0.011 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.011 | ||
| KAL1 | Kallmann syndrome 1 sequence | 0.011 | ||
| CTSB | cathepsin B | 0.011 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.011 | ||
| PDGFC | platelet derived growth factor C | 0.010 | ||
| ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 0.010 | ||
| KDM6B | lysine (K)-specific demethylase 6B | 0.010 | ||
| COMP | cartilage oligomeric matrix protein | 0.010 | Human | |
| ATP6AP2 | ATPase, H+ transporting, lysosomal accessory protein 2 | 0.010 | ||
| ZNF205 | zinc finger protein 205 | 0.010 | ||
| SIX3 | SIX homeobox 3 | 0.010 | ||
| ECM1 | extracellular matrix protein 1 | 0.010 | ||
| TLX1 | T-cell leukemia homeobox 1 | 0.010 | ||
| MAG | myelin associated glycoprotein | 0.010 | ||
| TBX21 | T-box 21 | 0.010 | ||
| PDPN | podoplanin | 0.010 | ||
| PTHLH | parathyroid hormone-like hormone | 0.010 | ||
| ACP5 | acid phosphatase 5, tartrate resistant | 0.010 | ||
| ZNF579 | zinc finger protein 579 | 0.010 | ||
| PLA1A | phospholipase A1 member A | 0.010 | ||
| FBLN2 | fibulin 2 | 0.010 | ||
| VTN | vitronectin | 0.010 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.010 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.010 |